论文部分内容阅读
目的:研究Molteno管植入术治疗穿透性角膜移植术后继发青光眼的手术疗效。方法:对9例眼部条件极差,经最大剂量药物治疗不能降低眼压的穿透性角膜移植术后青光眼施行Molteno管植入手术。结果:7例眼压控制在0.8～2.8kPa(1kPa=7.5mmHg)之间,成功率为77.78％(7/9);另两例需继续局部滴用β-受体阻滞剂,1例发生角膜排斤反应经药物治疗痊愈,1例角膜半透明,角膜植片透明率88.89％(8/9),术后视力有改善者4例,视力保持不变者4例,视力下降者1例,其中4例最好矫正视力大于0.05。结论:Molteno管植入术为角膜移植术后保留一定有视力而又不具作滤过性手术条件的难治性青光眼提供合理、有效的治疗方法。眼科学报1999;15:107-110。
Objective: To study the effect of Molteno tube implantation in the treatment of secondary glaucoma after penetrating keratoplasty. Methods: Nine cases of penetrating keratoplasty with glaucoma underwent maxillofacial ophthalmic injection of Molteno were implanted in 9 patients with poor ophthalmic conditions. Results: The intraocular pressure of 7 patients was controlled between 0.8-2.8kPa (1kPa = 7.5mmHg), the success rate was 77.78% (7/9). The other two patients needed continuous local application of β-blockers and 1 patient Corneal rejection occurred after drug treatment, 1 case of translucent cornea, corneal graft transparency rate of 88.89% (8/9), 4 cases of postoperative visual acuity improvement, unchanged vision in 4 cases, decreased visual acuity 1 Cases, of which 4 cases best corrected visual acuity greater than 0.05. CONCLUSIONS: Molteno tube implantation provides a reasonable and effective treatment for refractory glaucoma that retains certain visual acuity without filtering surgery after corneal transplantation. Journal of Ophthalmology 1999; 15: 107-110.